M. Jason Aryeh's Insider Trades & SAST Disclosures
M. Jason Aryeh's most recent trade in Orchestra BioMed Holdings Inc was a trade of 11,700 Common Stock, par value $0.0001 per share ("Common Stock") done at an average price of $4.3 . Disclosure was reported to the exchange on Dec. 27, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern M. Jason Aryeh.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Orchestra BioMed Holdings Inc | Jason M. Aryeh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 27 Dec 2024 | 11,700 | 80,060 | - | 4.3 | 50,310 | Common Stock, par value $0.0001 per share ("Common Stock") |
| Orchestra BioMed Holdings Inc | M. Jason Aryeh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 11,700 | 6,900 | - | - | Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 24,554 | 24,554 (0%) | 0% | - | Common Stock | |
| Orchestra BioMed Holdings Inc | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 17,068 | 17,068 | - | - | Stock Option (Right to Buy) | |
| Orchestra BioMed Holdings Inc | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 5,376 | 68,360 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| Ligand Pharmaceuticals, In... | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 5,444 | 5,444 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ligand Pharmaceuticals, In... | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 1,252 | 78,080 (0%) | 0% | 0 | Common Stock | |
| Anebulo Pharmaceuticals Inc | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 41,667 | 41,667 | - | - | Stock Option (right to buy) | |
| Anebulo Pharmaceuticals Inc | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 2,482 | 2,482 | - | - | Stock Option (right to buy) | |
| Ligand Pharmaceuticals, In... | Jason M. Aryeh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.30 per share. | 30 Apr 2024 | 2,406 | 76,828 (0%) | 0% | 52.3 | 125,834 | Common Stock |
| Ligand Pharmaceuticals, In... | Jason M. Aryeh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 2,406 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ligand Pharmaceuticals, In... | Jason M. Aryeh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2024 | 2,893 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ligand Pharmaceuticals, In... | Jason M. Aryeh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.35 per share. | 05 Mar 2024 | 2,893 | 74,422 (0%) | 0% | 39.4 | 113,840 | Common Stock |
| Orchestra BioMed Holdings Inc | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Ligand Pharmaceuticals, In... | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 5,461 | 5,461 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ligand Pharmaceuticals, In... | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 1,142 | 71,529 (0%) | 0% | 0 | Common Stock | |
| Orchestra BioMed Holdings Inc | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 23,250 | 23,250 | - | - | Nonstatutory Stock Option (Right to Buy) | |
| Ligand Pharmaceuticals, In... | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2022 | 4,484 | 4,484 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ligand Pharmaceuticals, In... | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 4,340 | 4,340 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ligand Pharmaceuticals, In... | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 1,004 | 69,668 (0%) | 0% | 0 | Common Stock | |
| Anebulo Pharmaceuticals Inc | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2022 | 30,425 | 30,425 | - | - | Stock Option (right to buy) | |
| Ligand Pharmaceuticals, In... | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 3,269 | 3,269 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ligand Pharmaceuticals, In... | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 630 | 68,664 (0%) | 0% | 0 | Common Stock | |
| Ligand Pharmaceuticals, In... | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 2,468 | 2,468 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ligand Pharmaceuticals, In... | Jason M. Aryeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 831 | 68,034 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges